AMANULLAH KHAN MD PHD NPI 1114922531

NPI Information

  • NPI: 1114922531
  • Provider Name: AMANULLAH KHAN, MD, PHD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4201 MEDICAL CENTER DR
    SUITE 180
    MCKINNEY, TX
    ZIP 75069
  • Phone: (214) 424-3615

Map and Directions

Get Directions

NPI Details

Amanullah Khan, MD, PHD is a hematology and oncology internal medicine in Mckinney, TX. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Amanullah Khan, MD, PHD NPI is 1114922531. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4201 MEDICAL CENTER DR
SUITE 180
MCKINNEY, TX
ZIP 75069-778
Phone: (214) 424-3615
Fax: (214) 905-7550

The NPI 1114922531 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Blood test, clotting time (HCPCS:85610)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Automated urinalysis test (HCPCS:81003)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 6/14/2005 and was last updated on 10/16/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyD8887TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1C17846MEDICARE UPINTEXAS
2838137MEDICARE ID-TYPE UNSPECIFIEDTEXAS
383503501MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.